Monday - February 23, 2026

Category Archives: Marketing & Sales

Balloon Valvuloplasty Device Market to Grow at 5.13% CAGR Through 2032, Driven by Rising Cardiovascular Disease Burden and Demand for Minimally Invasive Cardiac Procedures, states DelveInsight

Balloon Valvuloplasty Device Market Balloon valvuloplasty device manufacturers include BD, PFM Medical ag, NuMED, Balton, TORAY INDUSTRIES, INC., Translumina, InterValve Medical, Inc., OSYPKA AG, SURETECH MEDICAL INC., simeks, and others. The global Balloon Valvuloplasty Device Market is poised for steady … Continue reading →

Insulin Resistance Pipeline Expands as 20+ Pharma Companies Progress Novel Therapies Toward Market Entry, Finds DelveInsight

Insulin Resistance – Pipeline Insight, 2026 DelveInsight’s “Insulin Resistance – Pipeline Insight, 2026” report provides comprehensive insights about 20+ companies, including Corbus Pharmaceuticals Holdings, Inc., Kura Oncology, Inc, SCOHIA Pharma Inc, Atrogi, YUNOVIA CO.,LTD., PegBio, Eli Lilly and Company, Tonix … Continue reading →

Duchenne Muscular Dystrophy Market to Surpass USD 2.15 Billion in 2023, Poised for Robust Growth Across 7MM Through 2034 | DelveInsight

Duchenne Muscular Dystrophy Market Key companies influencing the Duchenne Muscular Dystrophy (DMD) therapeutic landscape include Capricor Therapeutics, Santhera Pharmaceuticals in partnership with ReveraGen Biopharma, Edgewise Therapeutics, FibroGen, Roche, Pfizer, Sarepta Therapeutics, Antisense Therapeutics, Italfarmaco, along with several other emerging and … Continue reading →

Chatoptic Introduces Paragraph-Level Citation Intelligence and Query Fan-Out Analysis to Transform AI Visibility Tracking

Pavel Israelsky, Co-Founder of Chatoptic, presenting the new AI Visibility dashboard features including paragraph-level citation mapping and query fan-out analysis. Chatoptic announces its most significant AI Visibility product update to date, introducing paragraph-level citation intelligence, cross-model query fan-out visibility, citation … Continue reading →

Acinetobacter Infections Pipeline Expands as 7+ Pharma Companies Progress Novel Therapies Toward Market Entry, Finds DelveInsight | Omnix Medical, Roche, Telum Therapeutics, Spero Therapeutics

Acinetobacter Infections – Pipeline Insight, 2026 DelveInsight’s “Acinetobacter Infections – Pipeline Insight, 2026” report provides comprehensive insights about 8+ companies, including Omnix Medical, Roche, Telum Therapeutics, Spero Therapeutics, VenatoRx Pharmaceuticals, ABAC Therapeutics, and others, developing 10+ pipeline drugs in the … Continue reading →

Metastatic Prostate Cancer Clinical Trial Pipeline Advances as 80+ Companies Develop 85+ Pipeline Drugs Across Multiple Stages, Finds DelveInsight | Merck, AstraZeneca, Syntrix Pharmaceuticals

Metastatic Prostate Cancer – Pipeline Insight, 2026 DelveInsight’s “Metastatic Prostate Cancer – Pipeline Insight, 2026” report provides comprehensive insights about 80+ companies including AstraZeneca, Arvinas, Daiichi Sankyo, Bristol Myers Squibb, Merck, MacroGenics, Seagen, Taiho Pharmaceutical, Modra Pharmaceuticals, Xencor, Point Biopharma, … Continue reading →

Uveitis Clinical Trial Pipeline Expands as 15+ Companies Advance 15+ Targeted Ocular Inflammation Therapies Toward Market Entry, Finds DelveInsight | Santen, Clearside Biomedical, Tarsier Pharma

Uveitis – Pipeline Insight, 2026 DelveInsight’s “Uveitis – Pipeline Insight, 2026” report provides comprehensive insights about 15+ companies, including Eli Lilly and Company, Santen Inc., Clearside Biomedical, Affibody, Eyevensys, Alcon Research, Panoptes Pharma, Tarsier Pharma, Eye Pharma, Apitope Technology, Mitotech, … Continue reading →

Degenerative Disc Disease Clinical Trial Pipeline Strengthens as 15+ Companies Advance 15+ Regenerative and Non‑Surgical Therapies Toward Market Entry, Finds DelveInsight | Spine BioPharma, Biosplice

“Degenerative Disc Disease – Pipeline Insight, 2026 DelveInsight’s “Degenerative Disc Disease – Pipeline Insight, 2026” report provides comprehensive insights about 15+ companies, including include Spine BioPharma, Inc., BioRestorative Therapies, Mesoblast Ltd., Biosplice Therapeutics, Causeway Therapeutics, AnGes Inc., DiscGenics, Kuros Biosciences, … Continue reading →

Celiac Disease Clinical Trial Pipeline Gains Momentum as 25+ Companies Advance Novel Therapies Toward Market Entry: DelveInsight | Teva Pharmaceutical Industries, Barinthus Biotherapeutics, Topas

Celiac Disease – Pipeline Insight, 2026 DelveInsight’s “Celiac Disease – Pipeline Insight, 2026” report provides comprehensive insights about 25+ companies, including Teva Pharmaceutical Industries Ltd., Sanofi, Forte Biosciences, Inc., Takeda, Anokion, Entero Therapeutics, Amgen, Topas Therapeutics, Mozart Therapeutics Australia Pty … Continue reading →